Baselight is shutting down June 30.
Export any data that you want to keep. Read the announcement.
Stocks
June 3, 2026
Anomaly01STOCKS
Laser Photonics Surges 160% on Military Technical Review Selection for Laser Shield System
- Laser Photonics shares surged after its Laser Shield Anti-Drone system was selected for a technical review program by the U.S. Department of War.
- The stock jumped 160.78% to close at $2.42 on June 2, with trading volume exploding to 275.71 million shares—224.5 times its 20-day average.
- The selection represents an early-stage evaluation milestone; advancing beyond the technical exchange may lead to follow-on prototyping and experimentation.
Outlier02STOCKS
Fulcrum Therapeutics Plunges 51% After Discontinuing Lead Sickle Cell Drug Over FDA Concerns
- Fulcrum Therapeutics suffered a massive selloff after halting its lead clinical program, pociredir, due to FDA concerns over malignancy risks.
- The stock plummeted 51.09% to close at $3.14 on June 2, while trading volume skyrocketed to 52.7 times its 20-day average.
- The discontinuation of its primary clinical asset represents a severe setback for the company's pipeline and raises doubts about its long-term viability.
Outlier03STOCKS
Abivax Suffers Severe 44% Drop on Ulcerative Colitis Trial Cancer Reports
- Abivax shares fell sharply following reports of non-melanoma skin cancers and other malignancies in its pivotal obefazimod study.
- The stock declined 44.10% to close at $72.50 on June 2, on volume that spiked to 11.6 times its 20-day average.
- Safety concerns in late-stage clinical trials can derail drug approvals, threatening the commercial future of Abivax's lead therapeutic candidate.
Trend Shift04STOCKS
Legend Biotech Surges 42% to Break Losing Streak on 100% Lymphoma Trial Success
- Legend Biotech shares rallied strongly after the company announced a 100% response rate in a Phase 1 trial for its experimental lymphoma treatment.
- The stock soared 42.22% to close at $36.28 on June 2, breaking a four-day losing streak on 5.9 times its average trading volume.
- Perfect efficacy results in early-stage trials bolster confidence in the company's next-generation CAR-T platform and its potential to treat aggressive cancers.
Divergence05STOCKS
Lowe's Hits 52-Week Low as Analysts Cut Quarterly Earnings Estimates
- Lowe's Companies fell to a new 52-week low as analysts cut their earnings expectations amid persistent housing market headwinds.
- The stock touched an intraday low of $204.51 on June 2, facing 27 downward EPS revisions and zero upward revisions over the last week.
- The downward revisions follow cautious forward guidance, reflecting concerns about high interest rates and cooling home improvement demand.
Trend Shift06STOCKS
MongoDB Surges 37% in Three Days on Strong Earnings Beat and Wall Street Upgrades
- MongoDB shares staged a massive multi-day rally fueled by a strong Q1 earnings beat and subsequent price target upgrades from major banks.
- The stock surged 37.10% over three days to close at $398.46 on June 2, supported by 31 upward EPS revisions for the current quarter.
- The sharp rebound reflects renewed investor confidence in MongoDB's cloud database platform and AI-driven growth prospects.